1 of 8
2 of 8
3 of 8
4 of 8
5 of 8
6 of 8
7 of 8
8 of 8
Monoclonal Mouse anti‑Human ACAA2 Antibody (clone OTI3H9, Carrier‑free, IHC, IF, WB) LS‑C788113
Monoclonal Mouse anti‑Human ACAA2 Antibody (clone OTI3H9, Carrier‑free, IHC, IF, WB) LS‑C788113
Antibody:
ACAA2 Mouse anti-Human Monoclonal (Carrier-free) (OTI3H9) Antibody
Format:
Unconjugated, Carrier-free
Overview
Antibody:
ACAA2 Mouse anti-Human Monoclonal (Carrier-free) (OTI3H9) Antibody
Format:
Unconjugated, Carrier-free
Specifications
Description
ACAA2 antibody LS-C788113 is an unconjugated mouse monoclonal antibody to human ACAA2. Validated for IF, IHC and WB.
Target
Human ACAA2
Synonyms
ACAA2 | Acetyl-CoA acyltransferase 2 | Acetyl-CoA acyltransferase | Beta-ketothiolase | DSAEC | Beta ketothiolase
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG2b
Monoclonal
Conjugations
Unconjugated
Purification
Purified from ascites.
Modifications
Carrier-free.
Also available
Unmodified.
Immunogen
Full length human recombinant protein of human ACAA2(NP_006102) produced in HEK293T cell.
Applications
- IHC (1:150)
- Immunofluorescence (1:100)
- Western blot (1:4000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
PBS, pH 7.3, 8% Trehalose
Reconstitution
Reconstitute with PBS pH 7.3. To use this carrier-free antibody for conjugation experiment, we strongly recommend you to perform another round of desalting process.
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Source:
E. coli
Tag:
His-GST
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/22/2024